Analytical Data
-
基因名
IL-7
- Application
-
别名
Pre-B-cell Growth Factor; Lymphopoietin-1
-
种属
Rat
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
> 95% as determined by SDS-PAGE.
-
蛋白编号
P56478
-
表达区间
His28~Asn151
-
分子量
44kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Interleukin-7 (IL-7) is a crucial cytokine involved in the development, survival, and maintenance of T and B lymphocytes, playing a vital role in the immune system. Research on recombinant IL-7 protein has gained significant attention due to its potential therapeutic applications in immunodeficiency disorders, such as HIV/AIDS, and in enhancing anti-tumor immunity in cancer treatments. In the context of HIV, IL-7 can stimulate the proliferation of T-cells, potentially restoring immune function in infected individuals. Moreover, studies suggest that IL-7 may aid in expanding T-cell populations, which is essential for effective vaccine responses and for improving overall immune surveillance against tumors. The recombinant form of IL-7 can be produced using various expression systems, allowing for large-scale production and facilitating its use in clinical settings. Additionally, ongoing research is investigating the safety, dosage, and efficacy of IL-7 in combination therapies for both immunotherapy and regenerative medicine. Understanding the mechanisms by which IL-7 regulates lymphocyte homeostasis and function will not only enhance our knowledge of immune system dynamics but also pave the way for innovative strategies to harness its properties for therapeutic benefit.
